Chapter 5 Respiratory Syncytial Virus
Respiratory syncytial virus (RSV) infection has an estimated global incidence of 33 million cases in children younger than 5 years, with 10% requiring hospital admission and up to 199,000 dying of the disease. There is growing evidence that severe infantile RSV bronchiolitis, a condition characteris...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Online |
| Lingua: | inglese |
| Pubblicazione: |
European Respiratory Society
2021
|
| Soggetti: | |
| Accesso online: | https://library.oapen.org/handle/20.500.12657/47857 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi: Chapter 5 Respiratory Syncytial Virus
- Current Insights Into Host Immune Responses to Human Respiratory Syncytial Virus (RSV) and Challenges Towards Efficient Treatments and Vaccines Against RSV
- Cross-Talk Between Inflammation and Barrier Framework at Mucosal Surfaces in the Lung: Implications for Infections and Pathology
- Human Respiratory Syncytial Virus Infection
- The Role of Innate Lymphoid Cells in Mucosal Immunity
- Inhaled Treatment of Respiratory Infections
- Immunity and Immunopathogenesis to Herpesviruses